Bills · S 1587
IN COMMITTEE· 119TH CONGRESS
Senate BillS 1587Health
Fair Prescription Drug Prices for Americans Act
INTRO MAY 5· LAST ACTION MAY 5
READING
3MIN
COSPONSORS
1
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill addresses a long-standing concern for many American voters: the high cost of prescription drugs. Compared to other developed nations, drug prices in the U.S. are often significantly higher, leading to affordability challenges for patients and higher healthcare costs overall. If this bill becomes law, it could lead to a noticeable drop in the retail prices of many medications, making them more accessible and easing financial burdens on millions of Americans.
Without this bill, drug manufacturers would continue to have broad discretion over pricing in the U.S. market, potentially maintaining or increasing current price disparities with other countries. Its passage would fundamentally change how drug prices are set in the U.S. by linking them to international benchmarks, whereas its failure would mean the current pricing system largely remains in place, leaving many to continue struggling with high drug costs.
KEY PROVISIONS
4AI-extractedPROVISION 01
Sets a maximum retail list price for certain prescription drugs and biological products in the U.S.
This directly caps the price consumers pay for many medications, potentially making them more affordable.
PROVISION 02
The maximum price is determined by the average retail list price of the drug in Canada, France, Germany, Italy, Japan, and the United Kingdom.
This provision introduces international price referencing, tying U.S. drug costs to prices in other developed nations.
PROVISION 03
Requires the Secretary of Health and Human Services to annually calculate this international average price and collect price data from manufacturers.
Establishes the mechanism and responsible party for enforcing the price cap and gathering necessary information.
PROVISION 04
Imposes a civil monetary penalty on manufacturers who sell drugs above the calculated international average price.
Provides a direct financial incentive for manufacturers to comply with the new pricing limits.
SPONSORSHIP
1 + 1
R· Missouri
YRS IN OFFICE
7
BILLS LED
51
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 1 REP 0 IND 0
ACTION TIMELINE
2 EVENTSMAY 5
Introduced in Senate
MAY 5
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 1587
Congress119th
StatusIn Committee
IntroducedMay 5, 2025
Last actionMay 5, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED MAY 5, 2025
Senate BillS 1587Health
Fair Prescription Drug Prices for Americans Act
INTRODUCED MAY 5, 2025· LAST ACTION MAY 5, 2025
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
1
COMPLEXITY
Moderate
